Novartis said in an emailed statement it had made good progress in implementing its new organisational structure that involved integrating ...

Even as there is still question hanging over the efficacy of hydroxychloroquine (HCQ) as medication for Covid-19, Swiss drug maker Novartis...

Novartis AG on Thursday scrapped the $1 billion sale of U.S. generic pill and skin drug assets to India's Aurobindo Pharma Ltd as regulator...

On Wednesday, shares of Aurobindo closed 4.8 per cent lower at Rs 450.75 on the BSE.

Paleja is currently country president at Novartis in India and is also responsible for the pharmaceuticals business in the country. He is a...

Under the terms of the agreement, both companies will share responsibility for end to end development, manufacturing and global regulatory ...

Biosimilars are identical copies of highly complex biologic drugs that are said to have the same efficacy.

On October 22, 2015, the USFDA had issued a warning letter to the company's Sandoz Division concerning Indian sites in Kalwe and Turbhe.

Sandoz, the generic drug arm of Swiss drug major Novartis, has received a warning letter from the US health regulator for violations of cur...

The observations in the warning letter dated October 22 are related to deficiencies in current good manufacturing practice (cGMP) for finis...

Sandoz, the generic drug arm of Swiss giant Novartis, has received a warning letter from the US FDA on October 22 for its two Indian sites ...

Cipla surged over 4% in trade after its partner Sandoz received a USFDA nod to launch a generic version of Pulmicort respules.

Drug firm Sandoz Inc is recalling India-made 1,023,430 units of anti-allergic Cetirizine HCl chewable tablets in the US due to impurity con...

The multi-layered deal involves UK-based GlaxoSmithKline acquiring Novartis's vaccine biz, while latter would purchase GSK's cancer drugs p...

Over 7,000 retailers and stockists had stopped selling all the 198 medicines of two firms from April 1, protesting the drugmakers’ practice...

An open battle has erupted between drug retailers in Mumbai and Novartis, a Swiss company, and its subsidiary Sandoz.

Pharmaceuticals maker Novartis AG reported a 7 percent rise in first-quarter net income on Monday on the back of a declining dollar and sol...